ArticleClinical rheumatology2026
Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007-2018.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation. Growing evidence suggests a link between insulin resistance (IR) and RA. However, the association of specific lipid-based IR indices, such as the Mffm/I index (Metabolic Score for Insulin Sensitivity), with RA prevalence remains underexplored. This study aimed to investigate the associations of the Mffm/I index and the Quantitative Insulin Sensitivity Check Index (QUICKI) with the prevalence of RA in a large, nationally representative population.
methodsThis cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2018. A total of 8,477 adult participants were included and categorized based on their RA status. The associations between Mffm/I, QUICKI (as both continuous variables and quartiles), and RA were evaluated using multivariable logistic regression models, adjusting for a comprehensive set of sociodemographic and clinical covariates. Results were presented as odds ratios (ORs) with 95% confidence intervals (CIs). Subgroup analyses, interaction tests, and mediation analyses were conducted to explore the consistency of these associations and the potential mediating role of obesity.
resultsOf the 8,477 participants, 549 (6.5%) reported a diagnosis of RA. After full adjustment for potential confounders, both the Mffm/I index and QUICKI demonstrated a significant inverse association with RA. In the fully adjusted model (Model 3), participants in the highest quartile (Q4) of Mffm/I had a 40% lower odds of RA (OR = 0.60, 95% CI: 0.45-0.79) compared to the lowest quartile (Q1). Similarly, the highest quartile of QUICKI was associated with a 28% lower odds of RA (OR = 0.72, 95% CI: 0.55-0.94). These negative associations were consistent across most predefined subgroups. Mediation analysis revealed that obesity significantly mediated the relationships, accounting for 43.87% of the total effect for Mffm/I and 51.04% for QUICKI.
conclusionThis study establishes a stable and robust inverse association between both the Mffm/I index and QUICKI and the prevalence of rheumatoid arthritis in the U.S. adult population. These findings highlight the potential role of insulin sensitivity in the pathophysiology of RA and suggest that obesity is a critical mediator in this relationship. These easily accessible indices may serve as valuable tools for risk assessment in clinical practice. Key Points • High insulin sensitivity is strongly associated with lower rheumatoid arthritis prevalence. • The novel lipid-based Mffm/I index is a robust indicator of RA prevalence. • Obesity mediates over 40% of the link between insulin resistance and RA. • Accessible insulin sensitivity indices may aid in clinical RA risk assessment.
Indexed as
Identifiers
41528638What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.